Figure 6.

Dyskinesia events observed through 12 months

The duration and severity of dyskinesia events (purple indicates mild; blue indicates moderate; orange indicates severe) were charted for each patient, as well as how many months after treatment they occurred. Overlapping events (e.g., generalized or orofacial dyskinesia) were reported in nine patients and are differentiated by Arabic numeral after case number. One event of dyskinesia (patient CU-03) that occurred at 43 months after treatment is not included in this graph. Black stars indicate events that occurred in patients who received gene therapy at an age >5 years. Red stars indicate events that occurred in patients who received a high dose.